Description
Z-Pro-D-Leu is a C-terminal peptide fragment of oxytocin that inhibits hypothermic tolerance induced by ethanol and analgesic and hypothermic tolerance induced by morphine; these effects may be dopamine-dependent.
Z-Pro-D-Leu is a C-terminal peptide fragment of oxytocin that inhibits hypothermic tolerance induced by ethanol and analgesic and hypothermic tolerance induced by morphine; these effects may be dopamine-dependent.
| Purity | ≥95% |
|---|---|
| Formula | C19H26N2O5 |
| Formula Wt. | 362.4 |
| Synonym | Z-P-D-L |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Szabó G, Kovács GL, Székeli S, et al. C-terminal fragments of oxytocin (prolyl-leucyl-glycinamide and Z-prolyl-D-leucine) attenuate the development of tolerance to ethanol. Acta Physiol Hung. 1987;69(1):115-22. PMID: 2884803.
Kovács GL, Izbéki F, Horváth Z, et al. Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/withdrawal are mediated by the limbic system. Behav Brain Res. 1984 Oct;14(1):1-8. PMID: 6542796.
Walter R, Ritzmann RF, Bhargava HN, et al. Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4573-6. PMID: 279936.
Jumonji histone demethylase inhibitor.
Carbonic anhydrase inhibitor.
Dual inhibitor of p70S6K and Akt.
Endogenous peptide hormone, GLP-1 fragment, inv...
Organosulfur, chelating agent.
STING antagonist
Casein kinase 1 inhibitor.
Triterpene saponin found in Bupleurum.
Thiazide-like diuretic; Kv7.1 and minK K+ chann...
Nicotinic acid derivative; InhA inhibitor.
Macrolide; protein translation inhibitor, mamma...
Alkaloid found in Fabaceae family plants; α3β...
Laminin-derived peptapeptide.
ACE inhibitor.
Inhibitor of Abl, c-Kit, and PDGFR.
Endogenous neuropeptide, involved in nociceptio...
Endogenous bombesin-like peptide, involved in f...
Tropane alkaloid found in plants in the Solanac...
Glycosylated isoflavone found in soy; TAS2R ago...
5-HT1A agonist, 5-HT2A antagonist.